seizures/kansè

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 5494 rezilta yo

Cerebral Granuloma Mimicking Malignant Neoplasm in Patient with Seizures 21 Years After Head Trauma.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Chronic posttraumatic cerebral granuloma is a rare, delayed complication of traumatic brain injury. Because of its late onset of symptoms and atypical appearance, the correct diagnosis of this rare lesion is difficult.A 49-year-old man presented with

New-onset seizure during and after brain tumor excision: a risk assessment analysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Prophylactic use of antiepileptic drugs (AEDs) in seizure-naïve brain tumor patients remains a topic of debate. This study aimed to characterize a subset of patients at highest risk for new-onset perioperative seizures (i.e., intraoperative and postoperative seizures occurring within 30

Primary, Dural-Based, Ewing Sarcoma Manifesting with Seizure Activity: Presentation of a Rare Tumor Entity with Literature Review.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Primary Ewing sarcoma arising from the calvarial bone and/or underlying dura matter are relatively rarely reported in the literature. Even rarer are considered to be those that originate from the dura and proliferate in both directions, toward the brain parenchyma and through the dura

[The management of patients with new epileptic seizures in the early period after resection of hemispheric tumors: two case reports and a literature review].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Epileptic seizures developing for the first time after a neurosurgical intervention (de novo seizures) are a challenge for choosing an optimal treatment. The pathogenesis of these seizures is often associated with factors that become inactive in the early postoperative period. These seizures can not

Perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The incidence of, and risk factors for, perioperative seizures and the need for perioperative antiepileptic drugs (AEDs) in previously seizure-free children with brain tumors remains unclear. The authors have undertaken a review of previously seizure-free pediatric patients with brain

Seizure outcome in children with hemispheric tumors and associated intractable epilepsy: the role of tumor removal combined with seizure foci resection.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Children harboring hemispheric tumors associated with intractable epilepsy were retrospectively reviewed to assess seizure outcome following tumor resection and electrocorticography-guided seizure foci removal. Thirteen (93%) of our patients have remained seizure-free, off anticonvulsants or on

Brain tumors presenting as a seizure disorder in infants.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Seizures occur in 25% to 40% of children with supratentorial tumors and are the presenting complaint in 10% to 15%. However, when divided by age, only 2% of children with seizures as the presenting complaint of brain tumors were less than 1 year of age. Three children, ranging in age from 20 days to

Seizures in patients with supratentorial oligodendroglial tumours. Clinicopathological features and management considerations.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In this study of 34 consecutive histologically confirmed oligodendroglial brain tumours (15 oligoastrocytoma, 12 oligodendroglioma, 7 anaplastic oligodendroglioma) twenty five patients (75%) presented with symptoms related to seizures. Although the seizure incidence was lowest in anaplastic

Seizure risk in brain tumor patients with conversion to generic levetiracetam.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Breakthrough seizure activity has been reported with conversion from brand name to generic anticonvulsants. This has prompted several organizations to support physician notification of generic substitution and patient consent. Recently, a generic formulation of levetiracetam has become available.

Cancer incidence in a cohort of patients with seizure disorders.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The incidence of cancer was evaluated in a population-based cohort of 959 patients diagnosed with seizure disorders while residents of Rochester, MN, between 1935 and 1979. For all cancer sites combined, there were 65 incidence cases for a standard morbidity ratio of 1.4. Most of the excess was

Levetiracetam for seizures in children with brain tumors and other cancers.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Children with brain tumors and other cancers can suffer from seizures. Unfortunately, most antiepileptic therapies are metabolized by the hepatic cytochrome P450 (CYP) system. Levetiracetam, a newer anticonvulsant, does not undergo CYP metabolism and does not alter the pharmacokinetics of

Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND The prevalence, risk factors, and clinical implication of seizure development were investigated in patients with metastatic brain tumors. METHODS Medical records and radiological findings were analyzed retrospectively in 258 patients with brain metastasis from lung cancer who underwent

Cortical hemosiderin is associated with seizures in patients with newly diagnosed malignant brain tumors.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hemorrhage is common in brain tumors. Due to characteristic magnetic field changes induced by hemosiderin it can be detected using susceptibility weighted MRI (SWI). Its relevance to clinical syndromes is unclear. Here we investigated the patterns of intra-tumoral SWI positivity (SWI(pos)) as a

Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Levetiracetam (LEV) is a newer anticonvulsant with a favorable safety profile. There seem to be no relevant drug interactions, and an intravenous formulation is available. Therefore, LEV might be a suitable drug for the perioperative anticonvulsive therapy of patients with suspected brain

Do prophylactic anticonvulsants in patients with brain tumors decrease the incidence of seizures?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The well-done systematic review included a moderate number of patients from randomized controlled trials with an objective diagnosis of a brain tumor. There were mild differences between the 5 studies used in the systematic review with patients in 3 of the studies undergoing surgical resection or

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye